Loading chat...
IN HB1061
Bill
Status
1/4/2017
Primary Sponsor
Robin Shackleford
Click for details
AI Summary
-
Adds new Chapter 17.5 to Indiana Code defining Lyme disease as an infection transmitted by tick and caused by Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii, or Borrelia garinii bacteria
-
Requires health care providers or their designees ordering a Lyme disease laboratory test to provide written information to patients or legal representatives
-
Written information must include that Lyme disease is the sixth fastest growing disease in the United States according to 2011 Centers for Disease Control and Prevention data
-
Information must explain that current laboratory testing for Lyme disease can produce false negative and false positive results, and early testing may not detect enough antibodies for a positive result
-
Information must advise that negative test results do not necessarily mean absence of Lyme disease, and patients with continuing symptoms should contact their health care provider about retesting or additional treatment
-
Effective date: July 1, 2017
Legislative Description
Lyme disease information. Requires a health care provider or health care provider's designee who orders a laboratory test for the presence of Lyme disease to provide the patient or the patient's legal representative with certain written information concerning Lyme disease.
Last Action
Representative Nisly added as coauthor
1/9/2017